Denmark’s Novo Nordisk expects 27% sales surge this year but faces price pressure for weight…
Novo Nordisk A/S raised its earnings forecast as the drugmaker now ships five times more introductory doses of the weight-loss drug Wegovy in the US than at the end of last year.
More than 25,000 patients are now starting treatment each…